Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Safety and Efficacy of CD19 CAR T-Cells for Pediatric Relapsed Acute Lymphoblastic Leukemia with Active CNS Involvement

Elad Jacoby, MD, Sara Ghorashian, FRCPath, PhD, Britta Julia Vormoor, MD, Barbara De Moerloose, MD, Nicole Bodmer, Michael Maschan, MD, Asaf David Yanir, MD, Bella Bielorai, MD, Srdan Rogosic, Olga Molostova, MD, Claudia Rossig, Amos Toren, MD PhD, Arend von Stackelberg, MD, Jean-Pierre Bourquin, MD PhD

Blood (2020) 136 (Supplement 1): 1.

https://doi.org/10.1182/blood-2020-141940

Published: 2020

Journal Articles

A Phase II Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Results of the ITCC-059 Study

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-134774

Published: 2020

Journal Articles

In Vitro Drug Response Profiling in BCP- and T-ALL Primary Samples Adds a Robust Functional Layer Enabling Optimized Guidance of Individualized Therapy in Relapsed and Refractory Pediatric Acute Leukemia Patients

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-142314

Published: 2020

Journal Articles

Osteonecrosis after Allogeneic HSCT in Children with High-Risk or Relapsed ALL Treated in the ALL-SCT 2003 Trial

Michaela Kuhlen, MD, Michael H. Albert, Peter Bader, MD PhD, Karoline Ehlert, MD, Tayfun Guengoer, Thomas Klingebiel, MD, Peter J. Lang, MD, Martin Schrappe, MD PhD, Johanna Schrum, MD, Ansgar S. Schulz, MD, Arend von Stackelberg, MD, Brigitte Strahm, PD Dr., Karl-Walter Sykora, MD, Irene Teichert-von Luettichau, MD, Arndt Borkhardt, Prof MD, Roland Meisel, MD, Ulrike Poetschger, Evgenia Glogova, Christina Peters, MD

Blood (2017) 130 (Supplement 1): 2004.

https://doi.org/10.1182/blood.V130.Suppl_1.2004.2004

Published: 2017

Journal Articles

Activation of Simultaneous Apoptosis and Necroptosis to Eradicate Drug Resistant Leukemia

Scott McComb, PhD, Julia Aguadé-Gorgorió, Blerim Marovca, Lena Harder, Gunnar Cario, Cornelia Eckert, Martin Schrappe, MD PhD, Martin Stanulla, MD, Arend von Stackelberg, MD, Jean-Pierre Bourquin, MD PhD, Beat Bornhauser, PhD

Blood (2015) 126 (23): 1283.

https://doi.org/10.1182/blood.V126.23.1283.1283

Published: 2015

Journal Articles

De Novo Purine Biosynthesis in Drug Resistance and Tumor Relapse of Childhood ALL

Hui Li, PhD, Benshang Li, Fan Yang, Caiwen Duan, Yun Bai, Jun J Yang, PhD, Jing Chen, MD PhD, Arend von Stackelberg, MD, Hongzhuan Chen, PhD, JingYan Tang, MD, Adolfo A. Ferrando, MD PhD, Jinghui Zhang, PhD, Shengyue Wang, Renate Kirschner-Schwabe, PhD, Bin-Bing S. Zhou, PhD

Blood (2015) 126 (23): 2627.

https://doi.org/10.1182/blood.V126.23.2627.2627

Published: 2015

Journal Articles

Clinical Significance of NT5C2 Mutations in Children with First Relapse of B-Cell Precursor Acute Lymphoblastic Leukemia

Jana Hof, MSc, Annabell Szymansky, MSc, Arend von Stackelberg, MD, Cornelia Eckert, PhD, Renate Kirschner-Schwabe, PhD

Blood (2014) 124 (21): 3789.

https://doi.org/10.1182/blood.V124.21.3789.3789

Published: 2014

Journal Articles

Results of a Feasibility and Phase II Study on Bortezomib (BTZ) in Pediatric Multiply Relapsed or Refractory Acute Lymphoblastic Leukemia: Complete Hematological Responses with a Modestly Intensive Regimen Including BTZ

Gertjan Kaspers, MD PhD, Denise Niewerth, MSc, Satianand Ramnarain, MSc, Andishe Attarbaschi, MD, André Baruchel, MD, Evelina S De Bont, MDPhD, Franca Fagioli, MD, Barbara De Moerloose, MD PhD, Karsten Nysom, MD, Giuseppe Palumbo, MD, Dirk Reinhardt, MD PhD, Pierre-Simon Rohrlich, MDPhD, Pauline Simon, MD, Arend von Stackelberg, MD, C. Michel Zwaan, MD PhD

Blood (2014) 124 (21): 2290.

https://doi.org/10.1182/blood.V124.21.2290.2290

Published: 2014

Journal Articles

Risk Factors, Treatment and Outcome of 2 nd Relapse of Acute Lymphoblastic Leukemia in Children. Results of the ALL-REZ BFM Registry

Junko Yamanaka, MD, Valentijn Bon, André Schrauder, Christina Peters, MD, Günter Henze, MD, Arend von Stackelberg, MD

Blood (2012) 120 (21): 668.

https://doi.org/10.1182/blood.V120.21.668.668

Published: 2012

Journal Articles

Outcome of Treatment for Relapsed Acute Lymphoblastic Leukemia in Children with Down Syndrome

Franziska Meyr, MD, Fabian Baumann, MD, Gabriele Escherich, MD, Georg Mann, MD, Thomas Klingebiel, MD, Andreas E Kulozik, MD, PhD, Claudia Rossig, MD, Martin Schrappe, Guenter Henze, MD, Arend von Stackelberg, MD, Johann K. Hitzler, MD

Blood (2012) 120 (21): 669.

https://doi.org/10.1182/blood.V120.21.669.669

Published: 2012

Journal Articles

Transient and Myeloid Leukemia in Children with Down Syndrome Mosaic

Alexandra Kolenova, MD, PhD, Katarina Reinhardt, PhD, Michaela Nathrath, MD, Claudia Rossig, MD, PhD, Arend von Stackelberg, MD, Christine von Neuhoff, MD, Annette Sander, MD, Peter Svec, MD, PhD, C. Michel Zwaan, MD, PhD, Ursula Creutzig, MD, PhD, Dirk Reinhardt, MD, PhD

Blood (2011) 118 (21): 2539.

https://doi.org/10.1182/blood.V118.21.2539.2539

Published: 2011

Journal Articles

Conventional Reinduction/Consolidation-Type Therapy Versus Short Course High Intensity Combination Chemotherapy As Post-Induction Treatment for Children with Relapsed Acute Lymphoblastic Leukemia. Early Results of Study ALL-REZ BFM 2002

Arend von Stackelberg, MD, Junko Yamanaka, MD, Gabriele Escherich, MD, Cornelia Eckert, PhD, Richard Ratei, MD, Johann K. Hitzler, MD, Georg Mann, MD, Lucie Sramkova, MD, Jean-Pierre Bourquin, MD, PhD, Martin Schrappe, MD, Günter Henze, MD

Blood (2011) 118 (21): 871.

https://doi.org/10.1182/blood.V118.21.871.871

Published: 2011

Journal Articles

Thirty Percent Long Term Survival In Children with Acute Leukemia and Complications Requiring Mechanical Ventilation

Daniel Steinbach, MD, Bernhard Wilhelm, MD, Hans-Rudolf Kiermaier, MD, Ursula Creutzig, MD, Martin Schrappe, MD, Martin Zimmermann, Klaus-Michael Debatin, MD, Bernd Gruhn, MD, Arend von Stackelberg, MD, Heribert Jürgens, MD, Brigitte Strahm, MD, Dirk Reinhardt, MD, PhD, Anja Möricke, MD

Blood (2010) 116 (21): 3243.

https://doi.org/10.1182/blood.V116.21.3243.3243

Published: 2010

Journal Articles

Therapeutic Efficacy of Natural Compounds From Viscum Album l. In Acute Lymphoblastic Leukemia

Catharina I. Delebinski, Sebastian Jaeger, Kristin Kemnitz-Hassanin, Arend von Stackelberg, MD, Günter Henze, Holger N. Lode, Georg Seifert

Blood (2010) 116 (21): 3261.

https://doi.org/10.1182/blood.V116.21.3261.3261

Published: 2010

Journal Articles

Allogeneic Hematopoetic Stem Cell Transplantation (SCT) In Children with ALL: Outcome of Matched Sibling Donor SCT (MSD-SCT) Is Equivalent to Unrelated Well Matched Donor HSCT (MD-HSCT) A Report From the Prospective International Multicenter Trial ALL-SCT-BFM 2003

Blood (2010) 116 (21): 530.

https://doi.org/10.1182/blood.V116.21.530.530

Published: 2010

Journal Articles

Poor Outcome for Children and Adolescents with Progressive Disease or Relapse of Lymphoblastic Lymphoma - a Report of the BFM Group

Birgit Burkhardt, MD, PhD, Alfred Reiter, MD, Eva Landmann, MD, Peter J. Lang, MD, Lisa Lassay, MD, Roswitha Dickerhoff, MD, Max Lakomek, MD, Guenter Henze, MD, Arend von Stackelberg, MD

Blood (2008) 112 (11): 3589.

https://doi.org/10.1182/blood.V112.11.3589.3589

Published: 2008

Journal Articles

Childhood Acute Lymphoblastic Leukemia: High Genomic Stability from Initial Diagnosis to Early Relapse.

Barbara Meissner, MD, Cornelia Eckert, PhD, Anja Moericke, MD, Arend von Stackelberg, MD, Renate Kirschner-Schwabe, PhD, Gunnar Cario, MD, André Schrauder, MD, Martin Zimmermann, PhD, Karl Welte, MD, Martin Schrappe, MD, Martin Stanulla, MD, MSc

Blood (2008) 112 (11): 1522.

https://doi.org/10.1182/blood.V112.11.1522.1522

Published: 2008

Journal Articles

Relapse in Childhood “Very High Risk” Acute Lymphoblastic Leukemia Treated with BFM Chemotherapy Has a Dismal Outcome Even When Treated with Transplantation.

Adriana Balduzzi, MD, Maria Grazia Valsecchi, PhD, André Schrauder, MD, Daniela Silvestri, MSc, Barbara Buldini, MD, Arend von Stackelberg, MD, Anna Maria Testi, MD, Thomas Klingebiel, MD, Christina Peters, MD, Carmelo Rizzari, MD, Elena Barisone, MD, Martin Schrappe, MD

Blood (2008) 112 (11): 915.

https://doi.org/10.1182/blood.V112.11.915.915

Published: 2008

Journal Articles

Purified Peripheral Autologous Stem Cell Transplant Versus Conventional Chemotherapy for Childhood Low Risk Relapsed Acute Lymphoblastic Leukemia.

Adriana Balduzzi, MD, Maria Grazia Valsecchi, PhD, Stefania Galimberti, MS, Sonia Bonanomi, MD, Giuseppe Gaipa, Mbsc, Maria Dassi, Mbsc, Paolo Perseghin, MD, Cornelia Eckert, MD, Simona Songia, Lt, Monica Manenti, Lt, Andrea Biondi, MD, Cornelio Uderzo, MD, Guenter Henze, MD, Arend von Stackelberg, MD

Blood (2006) 108 (11): 3074.

https://doi.org/10.1182/blood.V108.11.3074.3074

Published: 2006

Journal Articles

The Expression of LI-Cadherin in Bone Marrow Is Correlated with Clinical Outcome in Children with Acute Lymphoblastic Leukemia at First Relapse.

Shuling Wu, MD, Anay Marquetti Hernández, MD, Corinna Dietel, PhD, Arend von Stackelberg, MD, Guenter Henze, MD, Karl Seeger, MD, PhD, Reinhard Gessner, MD, PhD

Blood (2005) 106 (11): 1456.

https://doi.org/10.1182/blood.V106.11.1456.1456

Published: 2005

NARROW

Safety and Efficacy of CD19 CAR T-Cells for Pediatric Relapsed Acute Lymphoblastic Leukemia with Active CNS Involvement

A Phase II Study of Single-Agent Inotuzumab Ozogamicin in Pediatric CD22-Positive Relapsed/Refractory Acute Lymphoblastic Leukemia: Results of the ITCC-059 Study

In Vitro Drug Response Profiling in BCP- and T-ALL Primary Samples Adds a Robust Functional Layer Enabling Optimized Guidance of Individualized Therapy in Relapsed and Refractory Pediatric Acute Leukemia Patients

Osteonecrosis after Allogeneic HSCT in Children with High-Risk or Relapsed ALL Treated in the ALL-SCT 2003 Trial

Activation of Simultaneous Apoptosis and Necroptosis to Eradicate Drug Resistant Leukemia

De Novo Purine Biosynthesis in Drug Resistance and Tumor Relapse of Childhood ALL

Clinical Significance of NT5C2 Mutations in Children with First Relapse of B-Cell Precursor Acute Lymphoblastic Leukemia

Results of a Feasibility and Phase II Study on Bortezomib (BTZ) in Pediatric Multiply Relapsed or Refractory Acute Lymphoblastic Leukemia: Complete Hematological Responses with a Modestly Intensive Regimen Including BTZ

Risk Factors, Treatment and Outcome of 2 nd Relapse of Acute Lymphoblastic Leukemia in Children. Results of the ALL-REZ BFM Registry

Outcome of Treatment for Relapsed Acute Lymphoblastic Leukemia in Children with Down Syndrome

Transient and Myeloid Leukemia in Children with Down Syndrome Mosaic

Conventional Reinduction/Consolidation-Type Therapy Versus Short Course High Intensity Combination Chemotherapy As Post-Induction Treatment for Children with Relapsed Acute Lymphoblastic Leukemia. Early Results of Study ALL-REZ BFM 2002

Thirty Percent Long Term Survival In Children with Acute Leukemia and Complications Requiring Mechanical Ventilation

Therapeutic Efficacy of Natural Compounds From Viscum Album l. In Acute Lymphoblastic Leukemia

Allogeneic Hematopoetic Stem Cell Transplantation (SCT) In Children with ALL: Outcome of Matched Sibling Donor SCT (MSD-SCT) Is Equivalent to Unrelated Well Matched Donor HSCT (MD-HSCT) A Report From the Prospective International Multicenter Trial ALL-SCT-BFM 2003

Poor Outcome for Children and Adolescents with Progressive Disease or Relapse of Lymphoblastic Lymphoma - a Report of the BFM Group

Childhood Acute Lymphoblastic Leukemia: High Genomic Stability from Initial Diagnosis to Early Relapse.

Relapse in Childhood “Very High Risk” Acute Lymphoblastic Leukemia Treated with BFM Chemotherapy Has a Dismal Outcome Even When Treated with Transplantation.

Purified Peripheral Autologous Stem Cell Transplant Versus Conventional Chemotherapy for Childhood Low Risk Relapsed Acute Lymphoblastic Leukemia.

The Expression of LI-Cadherin in Bone Marrow Is Correlated with Clinical Outcome in Children with Acute Lymphoblastic Leukemia at First Relapse.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only